Literature DB >> 357754

Longterm treatment with brompheniramine and phenylpropanolamine in recurrent otitis media--a double-blind study.

N I Kjellman, H Harder, L Lindwall, B Synnerstad.   

Abstract

A double-blind study has been performed in 44 children with recurrent episodes of otitis media and/or secretory otitis media using a combined preparation of brompheniraminemaleate and phenylpropanolaminehydrocloride (Lunerin mite). No significant prophylactic effect was found on symptoms of respiratory tract infections or middle ear diseases during the trial period of nine months. The result suggests that further critical studies should be performed with such preparations which for the time being are used abundantly for the prevention of middle ear infections or effusions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357754

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  6 in total

1.  Hallucinations induced by an antihistamine-decongestant mixture: Should children use over-the-counter drugs?

Authors:  C V Fernandez
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

2.  Critical appraisal of medical literature: second update.

Authors:  M Labrecque; R Verreault; I Grava-Gubins
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

3.  An antihistamine decongestant in the prevention of acute otitis media in children with colds.

Authors:  R Brownoff; L J Hutchison
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 4.  Chemotherapy of rhinovirus colds.

Authors:  S J Sperber; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

5.  Visual hallucinations induced by a sympathomimetic drug.

Authors:  H Dungal; D E Griffiths
Journal:  Can Med Assoc J       Date:  1984-11-15       Impact factor: 8.262

Review 6.  Antihistamines and/or decongestants for otitis media with effusion (OME) in children.

Authors:  Glenn Griffin; Cheryl A Flynn
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.